Diane Warren

Dana Faber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS2
- SINCE2009

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
January 2009 - November 2010
Multiple Myeloma
Neoplasms, Plasma Cell
Bone Diseases
Placebo
Bhq880



